These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35354745)

  • 1. Localization of Late Gadolinium Enhancement and Its Association with Ventricular Tachycardia in Patients with Cardiac Sarcoidosis.
    Yodogawa K; Fukushima Y; Tachi M; Fujimoto Y; Hagiwara K; Oka E; Hayashi H; Murata H; Yamamoto T; Iwasaki YK; Amano Y; Kumita SI; Shimizu W
    Int Heart J; 2022; 63(2):235-240. PubMed ID: 35354745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
    Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
    Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
    Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of RV Abnormalities on CMR in Patients With Known or Suspected Cardiac Sarcoidosis.
    Wang J; Zhang J; Hosadurg N; Iwanaga Y; Chen Y; Liu W; Wan K; Patel AR; Wicks EC; Gkoutos GV; Han Y; Chen Y
    JACC Cardiovasc Imaging; 2023 Mar; 16(3):361-372. PubMed ID: 36752447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging.
    Kagioka Y; Yasuda M; Okune M; Kakehi K; Kawamura T; Kobuke K; Miyazaki S; Iwanaga Y
    Clin Res Cardiol; 2020 Aug; 109(8):988-998. PubMed ID: 31872264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
    Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
    Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis.
    Gowani Z; Habibi M; Okada DR; Smith J; Derakhshan A; Zimmerman SL; Misra S; Gilotra NA; Berger RD; Calkins H; Tandri H; Chrispin J
    Am J Cardiol; 2020 Nov; 134():123-129. PubMed ID: 32950203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Function follows form": Role of cardiac magnetic resonance for ventricular arrhythmia risk stratification in patients with cardiac sarcoidosis.
    Magnocavallo M; Vetta G; Polselli M; Cauti FM; Parlavecchio A; Caminiti R; Crea P; Pannone L; Sorgente A; Chimenti C; Chierchia GB; Rossi P; Natale A; de Asmundis C; Bianchi S; Della Rocca DG
    J Cardiovasc Electrophysiol; 2023 Aug; 34(8):1781-1784. PubMed ID: 37493490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function.
    Watanabe E; Kimura F; Nakajima T; Hiroe M; Kasai Y; Nagata M; Kawana M; Hagiwara N
    J Thorac Imaging; 2013 Jan; 28(1):60-6. PubMed ID: 23249970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of cardiac sarcoidosis in patients presenting with cardiac arrest or life-threatening arrhythmias.
    Hatipoglu S; Gardezi SKM; Azzu A; Baksi J; Alpendurada F; Izgi C; Khattar R; Kouranos V; Wells AU; Sharma R; Wechalekar K; Pennell DJ; Mohiaddin R
    Heart; 2023 Apr; 109(10):748-755. PubMed ID: 36627181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the Electroanatomic Substrate in Cardiac Sarcoidosis: Correlation With Imaging Findings of Scar and Inflammation.
    Muser D; Santangeli P; Liang JJ; Castro SA; Magnani S; Hayashi T; Garcia FC; Frankel DS; Dixit S; Zado ES; Lin D; Desjardins B; Callans DJ; Alavi A; Marchlinski FE
    JACC Clin Electrophysiol; 2018 Mar; 4(3):291-303. PubMed ID: 30089553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis.
    Hulten E; Agarwal V; Cahill M; Cole G; Vita T; Parrish S; Bittencourt MS; Murthy VL; Kwong R; Di Carli MF; Blankstein R
    Circ Cardiovasc Imaging; 2016 Sep; 9(9):e005001. PubMed ID: 27621357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis.
    Smedema JP; van Geuns RJ; Ector J; Heidbuchel H; Ainslie G; Crijns HJGM
    ESC Heart Fail; 2018 Feb; 5(1):157-171. PubMed ID: 28967698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
    Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
    JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late gadolinium enhancement on CMR and sustained ventricular tachycardia predict severe cardiac inflammation.
    Pöyhönen P; Holmström M; Kivistö S; Hänninen H
    Acta Cardiol; 2014 Dec; 69(6):637-47. PubMed ID: 25643434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis.
    Yang Y; Safka K; Graham JJ; Roifman I; Zia MI; Wright GA; Balter M; Dick AJ; Connelly KA
    J Magn Reson Imaging; 2014 Mar; 39(3):609-16. PubMed ID: 23720077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of fusion
    Okune M; Yasuda M; Soejima N; Kagioka Y; Kakehi K; Kawamura T; Hanaoka K; Kaida H; Ishii K; Nakazawa G; Miyazaki S; Iwanaga Y
    J Nucl Cardiol; 2022 Apr; 29(2):753-764. PubMed ID: 33000410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.
    Ise T; Hasegawa T; Morita Y; Yamada N; Funada A; Takahama H; Amaki M; Kanzaki H; Okamura H; Kamakura S; Shimizu W; Anzai T; Kitakaze M
    Heart; 2014 Aug; 100(15):1165-72. PubMed ID: 24829369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of late gadolinium-enhanced MRI in confirmed and suspected cardiac sarcoidosis: meta-analysis.
    Sekii R; Kato S; Horita N; Utsunomiya D
    Int J Cardiovasc Imaging; 2024 Aug; 40(8):1797-1807. PubMed ID: 39012402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.